Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
144.00    -1.00 (-0.69%)
Bid:
144.00
Ask:
145.00
Spread: 1.00 (0.694%)
Market Cap: £113.00m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

16 Apr 2009 07:00

RNS Number : 6219Q
Xaar PLC
16 April 2009
 



FOR IMMEDIATE RELEASE

16 April 2009

Xaar plc

INTERIM MANAGEMENT STATEMENT

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 January 2009 to 31 March 2009. 

Trading for the first quarter of the year, historically the Group's quietest trading period due to the Chinese New Year holiday in February, was in line with the Board's expectations at a level similar to that for Q1, 2008 and was stable at the levels seen in the third and fourth quarters of 2008.

 

The first of Xaar’s new second generation Platform 1 products, the Xaar Proton, was successfully launched during the period at the Sign China show in Guangzhou. Following the launch, sales of the Proton into China have been ahead of the Board’s expectations. The Proton will be released into India and Latin America during the course of 2009 as the Group’s OEM customers in those regions launch new printing machines incorporating the printheads. The Xaar Electron, the second new Platform 1 product, remains on course for its launch in customer printing machines at the Shanghai Ad show in early July.

Original Equipment Manufacturers in western markets continue to launch printing machines based on Xaar's Platform 3 (P3) technology with further product launches during the period. Whilst the number of OEM customers bringing printing machines based on P3 technology to market is encouraging, the transition from product launch to volume sales remains slow and cannot be expected to be immune from the effects of the global economic situation.

The Group has maintained its strong balance sheet throughout the period with gross cash at 31 March 2009 of £12.4m (31 December 2008: £11.6m). Total debt at 31 March 2009 was £0.6m (31 December 2008: £0.6m). The cash inflow during the period reflects both stable trading and the benefits of previously announced cost saving measures.

On 1 April 2009 the Group announced the rationalisation of its manufacturing facilities which will involve the eventual closure of its plant in StockholmSweden and the relocation of that manufacturing capability to the Group's manufacturing facility in HuntingdonEngland. This process is expected to take up to two years to complete and is expected to result in a substantial reduction in the Group's cost base.

The Board is encouraged by trading in Q1 but, given both a continuing lack of visibility of customer orders and the current uncertainty in the business environment due to the ongoing global economic situation, must remain cautious when looking forward. 

Ends

CONTACTS

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director 

Bankside Consultants:

Steve Liebmann

020-7367-8883 / 07802-888159

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBSGDSDBBGGCU
Date   Source Headline
27th Aug 20157:01 amRNS2015 Interim Results
26th Aug 20156:01 pmRNSHolding(s) in Company
3rd Aug 201510:25 amRNSTotal Voting Rights
8th Jul 20157:00 amRNSScheduled Trading Statement
7th Jul 20153:28 pmRNSHolding(s) in Company
1st Jul 20151:36 pmRNSBlocklisting Interim Review
1st Jul 20151:33 pmRNSTotal Voting Rights
5th Jun 20157:00 amRNSDirectorate Change
1st Jun 20151:16 pmRNSTotal Voting Rights
1st May 20151:27 pmRNSDirector Shareholding
1st May 201512:37 pmRNSTotal Voting Rights
27th Apr 201510:00 amRNSDirectorate Change
8th Apr 20153:58 pmRNSDirector/PDMR Shareholding
7th Apr 20154:33 pmRNSGrant of Options
7th Apr 20154:31 pmRNSDirector/PDMR Shareholding
31st Mar 20155:23 pmRNSTotal Voting Rights
27th Mar 201510:08 amRNSDirectorate Change
24th Mar 20152:15 pmRNSDirector/PDMR Shareholding
19th Mar 20157:00 amRNS2014 Full Year Results
3rd Mar 20159:51 amRNSTotal Voting Rights
2nd Mar 20157:00 amRNSDirector Appointment
16th Feb 20152:09 pmRNSDirectorate Change
2nd Feb 20155:52 pmRNSTotal Voting Rights
5th Jan 20157:00 amRNSAppointment of CEO
2nd Jan 201510:00 amRNSBlocklisting Interim Review
2nd Jan 201510:00 amRNSTotal Voting Rights
19th Dec 20142:34 pmRNSHolding(s) in Company
17th Dec 20147:00 amRNSTrading Update
16th Dec 20143:58 pmRNSHolding(s) in Company
15th Dec 201411:01 amRNSHolding(s) in Company
12th Dec 20149:31 amRNSHolding(s) in Company
1st Dec 20145:32 pmRNSTotal Voting Rights
27th Nov 20144:22 pmRNSHolding(s) in Company
3rd Nov 201412:34 pmRNSTotal Voting Rights
3rd Nov 201410:01 amRNSHolding(s) in Company
27th Oct 201412:48 pmRNSDirector/PDMR Shareholding
10th Oct 20149:57 amRNSHolding(s) in Company
7th Oct 20144:26 pmRNSHolding(s) in Company
6th Oct 20142:35 pmRNSHolding(s) in Company
3rd Oct 20145:12 pmRNSHolding(s) in Company
2nd Oct 20147:00 amRNSInterim Management Statement
1st Oct 20143:57 pmRNSTotal Voting Rights
30th Sep 20149:12 amRNSGrant of Options - Share Save
16th Sep 20142:56 pmRNSHolding(s) in Company
9th Sep 20143:11 pmRNSHolding(s) in Company
8th Sep 20143:02 pmRNSDirector/PDMR Shareholding
1st Sep 20145:41 pmRNSTotal Voting Rights
28th Aug 20147:00 amRNS2014 Interim Results
1st Aug 20141:11 pmRNSTotal Voting Rights
17th Jul 20147:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.